Single-dose pharmacokinetics of acyclovir and its principal metabolite 9-carboxymethoxymethylguanine (CMMG) in subjects with normal or impaired renal function and in hemodialysis patients

Anders Hellden

[P27-3-7] Single-dose pharmacokinetics of acyclovir and its principal metabolite 9-carboxymethoxymethylguanine (CMMG) in subjects with normal or impaired renal function and in hemodialysis patients

Anders Hellden¹, Lars Stahle² (1.Karolinska Institutet, 2.Intervention, and Technology)

Keywords:acyclovir, 9-carboxymethoxymethylguanine, neuropsychiatric symptoms, kidney function metabolism

Abstract password authentication.
Password to view abstracts and 'Participants' page is announced on the e-blast sent to early-bird/advanced registrants on September 13. It is also on the page 7 of IATDMCT 2017 PROGRAM BOOK.

Presentation information

[P27-3] P27-3: Anti-infective drugs (8): Antiviral

[P27-3-7] Single-dose pharmacokinetics of acyclovir and its principal metabolite 9-carboxymethoxymethylguanine (CMMG) in subjects with normal or impaired renal function and in hemodialysis patients

Password